Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MEI Pharma Inc (NASDAQ:MEIP)

1.97
Delayed Data
As of May 25
 +0.30 / +17.96%
Today’s Change
1.23
Today|||52-Week Range
2.28
+36.81%
Year-to-Date
Bristol-Myers' Opdivo Gets Priority Review for Liver Cancer
May 25 / Zacks.com - Paid Partner Content
Alexion's (ALXN) Strensiq Results Positive in Long-Term Study
May 17 / Zacks.com - Paid Partner Content
Achaogen's Plazomicin Gets Breakthrough Therapy Designation
May 24 / Zacks.com - Paid Partner Content
Kamada (KMDA) Posts Q1 Loss Wider than Expected, Sales Miss
May 17 / Zacks.com - Paid Partner Content
Catalyst Pharmaceuticals Focuses on Development of Firdapse
May 23 / Zacks.com - Paid Partner Content
Reasons to Add Puma Biotechnology (PBYI) to Portfolio Now
May 17 / Zacks.com - Paid Partner Content
Calithera Biosciences (CALA) Jumps: Stock Moves 17% Higher
May 22 / Zacks.com - Paid Partner Content
Minerva (NERV) Provides Phase III Development Strategy for MIN-101
May 16 / Zacks.com - Paid Partner Content
Vertex Ups Kalydeco Sales View as FDA Okays Label Expansion
May 18 / Zacks.com - Paid Partner Content
Ionis (IONS) Stock Falls Despite Positive Inotersen Data
May 16 / Zacks.com - Paid Partner Content